Please login to the form below

Not currently logged in
Email:
Password:

Flulaval Quadrivalent

This page shows the latest Flulaval Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

China weighs heavy on GSK figures in Q3

China weighs heavy on GSK figures in Q3

Witty emphasised that GSK is entering a new product launch phase with four approvals since the start of the year - including quadrivalent flu vaccine FluLaval and Tyverb (lapatinib) for use alongside

Latest news

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    FDA approves Flulaval Quadrivalent.  . GlaxoSmithKline has secured US approval for a second four-strain (quadrivalent) influenza vaccine in time for the upcoming flu season. ... The latest approval is for Flulaval Quadrivalent, which has been given the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics